TABLE 3

Relative Differences (%) and Absolute Differences (SUV) on Elevated Uptake VOIs

Relative difference (%)
LocationTissuenAC methodMean ± SDMinimumMaximumAbsolute difference (SUV)P
AbPe15NSEGbase−3.07 ± 3.47−7.923.91−0.09 ± 0.490.1808
AbPe15NSEGwBONEpe−3.22 ± 2.51−7.420.20−0.19 ± 0.270.0034*
AbPe15NSEGwBONEad−4.39 ± 2.04−7.98−1.57−0.35 ± 0.300.0007*
AbPe13NBSEGbase−3.42 ± 2.95−9.080.21−0.12 ± 0.110.0029*
AbPe13NBSEGwBONEpe−2.00 ± 3.10−5.752.74−0.08 ± 0.140.1377
AbPe13NBSEGwBONEad−4.10 ± 3.02−8.200.32−0.18 ± 0.160.0037*
Th6NSEGbase−6.70 ± 5.38−12.78−0.70−0.26 ± 0.240.0750
Th6NSEGwBONEpe−0.74 ± 4.36−6.425.98−0.05 ± 0.160.7500
Th6NSEGwBONEad0.19 ± 7.37−9.5611.46−0.04 ± 0.261.0000
Th8NBSEGbase−2.42 ± 6.51−9.709.120.18 ± 0.970.5531
Th8NBSEGwBONEpe5.63 ± 5.19−1.9914.190.64 ± 1.340.0781
Th8NBSEGwBONEad2.34 ± 3.87−2.599.710.39 ± 0.970.2604
  • * Statistically significant differences.

  • VOIs are placed in abdomen/pelvis (AbPe) and thorax (Th) at locations in normal tissue (N) and near bone (NB) averaged over all evaluated patients.